Day One Biopharmaceuticals, Inc.
DAWN
$7.24
-$0.20-2.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.21% | 48.77% | 45.14% | 37.69% | -18.29% |
| Total Receivables | 115.29% | -- | -- | -- | -- |
| Inventory | 4,233.11% | -- | -- | -- | -- |
| Prepaid Expenses | 27.26% | 21.80% | 58.93% | 30.53% | 58.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.10% | 112.65% | 45.24% | 56.61% | 83.93% |
| Total Current Assets | 29.04% | 56.01% | 49.85% | 40.58% | -14.81% |
|
|
|||||
| Total Current Assets | 29.04% | 56.01% | 49.85% | 40.58% | -14.81% |
| Net Property, Plant & Equipment | 1,237.78% | 1,045.27% | 740.54% | 430.99% | -49.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.71% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.41% | 28.74% | -43.46% | -49.79% | -54.83% |
| Total Assets | 29.62% | 63.59% | 54.98% | 45.06% | -11.16% |
|
|
|||||
| Total Accounts Payable | -21.01% | -46.86% | 26.63% | -11.03% | 41.16% |
| Total Accrued Expenses | 52.49% | 69.88% | 121.56% | 51.67% | 49.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.47% | -79.33% | -97.55% | -82.38% | -55.61% |
| Total Finance Division Other Current Liabilities | -96.82% | 437.87% | 1,217.77% | 1,356.48% | 31,153.76% |
| Total Other Current Liabilities | -96.82% | 437.87% | 1,217.77% | 1,356.48% | 31,153.76% |
| Total Current Liabilities | -45.34% | 60.46% | 148.92% | 62.39% | 282.29% |
|
|
|||||
| Total Current Liabilities | -45.34% | 60.46% | 148.92% | 62.39% | 282.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 3,196.10% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -37.89% | 83.80% | 171.24% | 84.69% | 279.35% |
|
|
|||||
| Common Stock & APIC | 29.94% | 30.79% | 31.25% | 31.51% | 6.14% |
| Retained Earnings | -18.08% | -13.26% | -20.82% | -20.86% | -46.79% |
| Treasury Stock & Other | -318.18% | -940.00% | 833.33% | 14.29% | -144.44% |
| Total Common Equity | 50.24% | 61.56% | 45.08% | 42.56% | -28.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.24% | 61.56% | 45.08% | 42.56% | -28.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 50.24% | 61.56% | 45.08% | 42.56% | -28.01% |
|
|
|||||